Comparison of tests of β-cell function across a range of glucose tolerance from normal to diabetes

Diabetes

Volumn 48, Issue 9, 1999, Pages 1779-1786

  Hermans, Michel P ^a,b   Levy, Jonathan C ^a   Morris, Richard J ^a   Turner, Robert C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ACCURACY; ADULT; AGED; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISCRIMINANT ANALYSIS; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MATHEMATICAL MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOIMMUNOASSAY; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 0032834004     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.9.1779     Document Type: Article

References (46)

1. Ward WK, Johnston CLW, Beard JC, Benedetti TJ, Halter JB, Porte D Jr: Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus. Diabetes 34:861-869, 1985
2. UK Prospective Diabetes Study Group: UK Prospective Diabetes Study V: characteristics of newly presenting type 2 diabetic patients: estimated insulin sensitivity and islet β-cell function. Diabet Med 5:444-448, 1988
3. DeFronzo RA: Lilly Lecture 1987: the triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-687, 1988
4. Eriksson J, Franssila Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343, 1989
5. Beck Nielsen H, Groop LC: Metabolic and genetic characterization of prediabetic states: sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 94:1714-1721, 1994
6. Zawalich WS, Kelley GG: The pathogenesis of NIDDM: the role of the pancreatic beta cell. Diabetologia 38:986-991, 1995
7. Reaven GM: The fourth musketeer - from Alexandre Dumas to Claude Bernard. Diabetologia 38:3-13, 1995
8. Groop L: Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 36:1326-1331, 1993
9. Taylor SI, Accili D, Imai Y: Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes 43:735-740, 1994
10. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinbum B, Bogardus C: Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. A' Engl J Med 318:1217-1225, 1988
11. Cook JT, Page RC, Levy JC, Hammersley MS, Walravens EK, Turner RC: Hyperglycaemic progression in subjects with impaired glucose tolerance: association with decline in beta cell function. Diabet Med 10:321-326, 1993
12. UK Prospective Diabetes Study Group: UK Prospective Diabetes Study 16: overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44:1249-1258, 1995
13. Galvin P, Ward G, Walters J, Pestell R, Koschmann M, Vaag A, Martin I, Best JD, Alford F: A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabet Med 9: 921-928, 1992
14. Coppack SW, Thursfield V, Dhar H, Hockaday TD: Comparison of indices of islet B-cell function in type 2 diabetes in relation to insulin effectiveness and clinical outcome. Diabet Med 8:629-637, 1991
15. Davis SN, Piatti PM, Monti L, Moller N, Ng LL, Coppack S, Antsiferov M, Brown MD, Alberti KG: A comparison of four methods for assessing in vivo beta-cell function in normal, obese and non-insulin-dependent diabetic man. Diabetes Res 19:107-117, 1992
16. Ganda OP, Srikanta S, Brink SJ, Morris MA, Gleason RE, Soeldner JS, Eisenbarth GS: Differential sensitivity to β-cell secretagogues in "early," type I diabetes mellitus. Diabetes 33:516-521, 1984
17. Pacini G, Bergman RN: MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113-122, 1986
18. Scheen AJ, Castillo MJ, Lefebvre PJ: Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications. Diabetes Metab 22:397-406, 1996
19. Smith C, Tarn A, Thomas J, Overkamp D, Corakci A, Savage M, Gale E: Between and within subject variation of the first phase insulin response to intravenous glucose. Diabetolegia 31:123-125, 1988
20. McCulloch DK, Palmer JP: The appropriate use of B-cell function testing in the preclinical period of type 1 diabetes. Diabetic Med 8:800-804, 1991
21. McCulloch DK, Bingley PJ, Colman PG, Jackson RA, Gale EAM, the ICARUS Group: Comparison of bolus and infusion protocols for determining acute insulin response to intravenous glucose in normal humans. Diabetes Care 16: 911-915, 1993
22. Bingley PJ, Colman P, Eisenbarth GS, Jackson RA, McCulloch DK, Riley WJ, Gale EAM: Standardization of IVGTT to predict IDDM. Diabetes Care 15: 1313-1316, 1992
23. McNair PD, Colman PG, Alford FP, Harrison LC: Reproducibility of the first-phase insulin response to intravenous glucose is not improved by retrograde cannulation and arterialization or the use of a lower glucose dose. Diabetes Care 18:1168-1173, 1995
24. Scheen A, Gorus F, Letiexhe MR, Craen R, De Leeuw I, Dorchy H, Somers G, Sodoyez J: Reproductibilité de la réponse insulinique précoce à l'injection intraveineuse de glucose: une étude multicentrique dans le cadre du Registre Belge du Diabète (Abstract). Diabetes Metab 21:22, 1995
25. Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Darling P, Bown EG, Turner RC: Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man. Diabetologia 28:401-411, 1985
26. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetalogia 28:412-419, 1985
27. Levy J, Rudenski A, Burnett M, Knight R, Matthews D, Turner R: Simple empirical assessment of β-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 34:488-499, 1991
28. Rudenski A, Matthews D, Levy J, Turner R: Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes. Metabolism 40:908-917, 1991
29. Turner R, Levy J, Rudenski A, Hammersley M, Page R: Measurement of insulin resistance and beta-cell function: the HOMA and CIGMA approach. In Current Topics in Diabetes Research. Belflore F, Bergman R, Molinatfi G, Eds. Basel, Karger, 1993, p. 66-75
30. Levy J, Matthews D, Hermans M: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191-2192, 1998
31. Nijpels G, van der Wal PS, Bouter LM, Heine RJ: Comparison of three methods for the quantification of beta-cell function and insulin sensitivity. Diabetes Res Clin Pract 26:189-195, 1994
32. Ganda OP, Day JL, Soeldner JS, Connon JJ, Gleason RE: Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes 27:715-725, 1978
33. Riggs D, Guarnieri J, Addelman S: Fitting straight lines when both variables are subject to error. Life Sci 22:1305-1360, 1978
34. Godfrey K: Simple linear regression in medical research. N Engl J Med 313: 1629-1636, 1985
35. Spilker B: Validation of clinical tests and measures. In Guide to Clinical Trials. New York, Raven Press, 1991, p. 313-319
36. British Standards Institution: Precision of Test Methods I: Guide for the Determination and Reproducibility for a Standard Test Method. London, British Standards Institution, 1979
37. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310, 1986
38. Levy JC, Hammersley M, Morris RJ, Turner RC: Comparison of imprecise physiological tests: discrimination, maximum expected rank correlation and unbiased equivalence. Am J Physiol 276:E365-E37, 1999
39. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
40. Hansen IL, Cryer PE, Rizza RA: Comparison of insulin-mediated and glucose-mediated glucose disposal in patients with insulin-dependent diabetes mellitus and in nondiabetic subjects. Diabetes 34:751-755, 1985
41. Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377, 1992
42. Bergman R, Finegood D, Ader M: Assessment of insulin sensitivity in vivo. Endocrine Rev 6:45-86, 1985
43. Hosker JP, Rudenski AS, Burnett MA, Matthews DR, Turner RC: Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. Metabolism 38:767-772, 1989
44. Bergman RN: Lilly Lecture 1989: Toward physiological understanding of glucose tolerance: minimal-model approach. Diabetes 38:1512-1527, 1989
45. Levy J, Manley S, Sutton P, Camps I: Beta-cell function assessed by the fasting hyperglycaemic clamp: reproducibility compared with HOMA analysis from fasting values, and factors influencing variability (Abstract). Diabetes 44 (Suppl. 1):89A, 1995
46. Hermans M, Coppack S, Levy J: Comparison of the efficiency of 4 in vivo insulin sensitivity tests to discriminate between individuals over the range of glucose tolerance by assessment of their discriminant ratio (Abstract). Diabetes 44 (Suppl. 1):200A, 1995